recently reported, the injectable antiretroviral drug cabotegravir given every eight weeks was found to be equivalent to daily oral Truvada.
Researchers from Kaiser Permanente San Francisco will present long-term follow-up data from Kaiser's large PrEP program. The Kaiser team recently reported that gay and bisexual men taking on-demand PrEP before and after sex — also known as PrEP 2-1-1 — had good adherence and none were diagnosed with HIV.